文献速递乳腺技术与安全MR

基于乳腺MRI的瘤周区域特征与乳腺癌预后相关性的系统综述与Meta分析

Association of peritumoral region features assessed on breast MRI and prognosis of breast cancer: a systematic review and meta-analysis.
PubMed 文献 · Eur Radiol · 2024-02-09

该系统综述与Meta分析纳入24项观察性研究(1853例预后不良乳腺癌与2590例对照),评估乳腺MRI瘤周区域特征与预后不良因素的关系。结果显示瘤周水肿、邻近血管征、较高的瘤周-肿瘤ADC比值及瘤周ADCmean与乳腺癌预后不良显著相关,推荐评估瘤周区域范围为距肿瘤边缘2-20 mm。

要点

  • 瘤周水肿与组织学高级别、Ki-67高表达、淋巴结转移、HR阴性等预后不良因素正相关。
  • 邻近血管征与预后不良乳腺癌的比值比升高相关(OR=2.02)。
  • 预后不良乳腺癌的瘤周-肿瘤ADC比值及瘤周ADCmean均较高,推荐评估瘤周区域为距肿瘤边缘2-20 mm。

核心结论

  • 瘤周水肿、邻近血管征、较高的瘤周-肿瘤ADC比值及瘤周ADCmean与乳腺癌预后不良显著相关。

研究设计与样本

  • 对截至2022年10月发表的观察性研究进行的回顾性Meta分析,纳入24项研究,共1853例预后不良乳腺癌与2590例对照,采用随机效应模型估计合并OR或SMD及95%CI,用I²统计量衡量异质性,并按研究特征进行敏感性分析。

关键影像表现/征象

  • 瘤周水肿与预后不良乳腺癌相关,包括非管腔型、Ki-67高表达、组织学高级别、淋巴结转移、HR阴性表达及淋巴血管侵犯。
  • 邻近血管征与预后不良乳腺癌的比值比升高相关(OR=2.02;95%CI:1.68,2.44;p=.000)。
  • 预后不良乳腺癌的瘤周-肿瘤ADC比值较高(SMD=0.67;95%CI:0.54,0.79;p=.000)。
  • 预后不良乳腺癌的瘤周ADCmean较高(SMD=0.29;95%CI:0.15,0.42;p=.000)。

诊断标准与关键数值

  • 瘤周水肿与非管腔型乳腺癌相关(OR=3.56;95%CI:2.17,5.83;p=.000)。
  • 瘤周水肿与Ki-67指数高表达相关(OR=3.70;95%CI:2.41,5.70;p=.000)。
  • 瘤周水肿与组织学高级别相关(OR=5.85;95%CI:3.89,8.80;p=.000)。
  • 瘤周水肿与淋巴结转移相关(OR=2.83;95%CI:1.71,4.67;p=.000)。
  • 瘤周水肿与HR阴性表达相关(OR=3.15;95%CI:2.03,4.88;p=.000),与淋巴血管侵犯相关(OR=1.72;95%CI:1.28,2.30;p=.000)。

临床应用与阅片要点

  • 乳腺MRI评估时可将瘤周水肿和邻近血管征作为提示预后不良的影像征象进行报告。
  • 测量ADC时建议评估距肿瘤边缘2-20 mm的瘤周区域,并计算瘤周-肿瘤ADC比值及瘤周ADCmean。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

BACKGROUND: Increasing attention has been given to the peritumoral region. However, conflicting findings have been reported regarding the relationship between peritumoral region features on MRI and the prognosis of breast cancer.

PURPOSE: To evaluate the relationship between peritumoral region features on MRI and prognosis of breast cancer.

MATERIALS AND METHODS: A retrospective meta-analysis of observational studies comparing either qualitative or quantitative assessments of peritumoral MRI features on breast cancer with poor prognosis and control subjects was performed for studies published till October 2022. Pooled odds ratios (ORs) or standardized mean differences and 95% confidence intervals (CIs) were estimated by using random-effects models. The heterogeneity across the studies was measured using the statistic I2. Sensitivity analyses were conducted to test this association according to different study characteristics.

RESULTS: Twenty-four studies comprising 1853 breast cancers of poor prognosis and 2590 control participants were included in the analysis. Peritumoral edema was associated with non-luminal breast cancers (OR=3.56; 95%CI: 2.17, 5.83; p=.000), high expression of the Ki-67 index (OR=3.70; 95%CI: 2.41, 5.70; p =.000), high histological grade (OR=5.85; 95%CI: 3.89, 8.80; p=.000), lymph node metastasis (OR=2.83; 95%CI: 1.71, 4.67; p=.000), negative expression of HR (OR=3.15; 95%CI: 2.03, 4.88; p=.000), and lymphovascular invasion (OR=1.72; 95%CI: 1.28, 2.30; p=.000). The adjacent vessel sign was associated with greater odds of breast cancer with poor prognosis (OR=2.02; 95%CI: 1.68, 2.44; p=.000). Additionally, breast cancers with poor prognosis had higher peritumor-tumor ADC ratio (SMD=0.67; 95%CI: 0.54, 0.79; p=.000) and peritumoral ADCmean (SMD=0.29; 95%CI: 0.15, 0.42; p=.000). A peritumoral region of 2-20 mm away from the margin of the tumor is recommended.

CONCLUSION: The presence of peritumoral edema and adjacent vessel signs, higher peritumor-tumor ADC ratio, and peritumoral ADCmean were significantly correlated with poor prognosis of breast cancer.

CLINICAL RELEVANCE STATEMENT: MRI features of the peritumoral region can be used as a non-invasive index for the prognostic evaluation of invasive breast cancer.

KEY POINTS: • Peritumoral edema was positively associated with non-luminal breast cancer, high expression of the Ki-67 index, high histological grade, lymph node metastasis, negative expression of HR, and lymphovascular invasion. • The adjacent vessel sign was associated with greater odds of breast cancers with poor prognosis. • Breast cancers with poor prognosis had higher peritumor-tumor ADC ratio and peritumoral ADCmean.

来源:Eur Radiol,查看原文。版权归原作者所有。

引用

  1. Zhao S, Li Y, Ning N, et al. Association of peritumoral region features assessed on breast MRI and prognosis of breast cancer: a systematic review and meta-analysis. Eur Radiol. 2024. PMID: 38334760. doi:10.1007/s00330-024-10612-y

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。